Perspectives: towards a peptide-based vaccine against hepatitis C virus. (Q43035611)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11741697%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

title

Perspectives: towards a peptide-based vaccine against hepatitis C virus (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11741697%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

1 reference

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11741697%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

author name string

I P Hunziker

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11741697%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

R Zurbriggen

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11741697%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

R Glueck

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11741697%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

O B Engler

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11741697%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

J Reichen

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11741697%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

W J Dai

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11741697%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

A Cerny

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11741697%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

publication date

1 December 2001

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11741697%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11741697%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

volume

38

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11741697%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11741697%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

page(s)

475-484

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11741697%20AND%20SRC:MED&resulttype=core&format=json

T cell priming versus T cell tolerance induced by synthetic peptides

4 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900083-9

7 January 2021

Peptide antigen treatment of naive and virus-immune mice: antigen-specific tolerance versus immunopathology

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900083-9

7 January 2021

Formation of virosomes from influenza subunits and liposomes

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900083-9

7 January 2021

Epidemiology of hepatitis C

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900083-9

7 January 2021

Correlation between virus genotype and chronicity rate in acute hepatitis C.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900083-9

7 January 2021

Induction of cytotoxic T lymphocyte activity by fusion-active peptide-containing virosomes

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900083-9

7 January 2021

Patients with chronic hepatitis C have circulating cytotoxic T cells which recognize hepatitis C virus-encoded peptides binding to HLA-A2.1 molecules

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900083-9

7 January 2021

Approaches to improve engineered vaccines for human immunodeficiency virus and other viruses that cause chronic infections

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900083-9

7 January 2021

Design of highly immunogenic liposomal constructs combining structurally independent B cell and T helper cell peptide epitopes

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900083-9

7 January 2021

Efficacy of synthetic vaccines in the induction of cytotoxic T lymphocytes. Comparison of the costimulating support provided by helper T cells and lipoamino acid

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900083-9

7 January 2021

Hepatitis C virus: molecular biology and genetic variability

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900083-9

7 January 2021

Preparation, properties, and applications of reconstituted influenza virus envelopes (virosomes).

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900083-9

7 January 2021

Genetic Heterogeneity of Hepatitis C Virus: Quasispecies and Genotypes

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900083-9

7 January 2021

Immunization with recombinant canarypox vectors expressing membrane-anchored glycoprotein 120 followed by glycoprotein 160 boosting fails to generate antibodies that neutralize R5 primary isolates of human immunodeficiency virus type 1.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900083-9

7 January 2021

Pathogenesis of chronic hepatitis C: immunological features of hepatic injury and viral persistence.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900083-9

7 January 2021

Cytotoxic T lymphocyte response to hepatitis C virus-derived peptides containing the HLA A2.1 binding motif

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900083-9

7 January 2021

Persistence of HCV despite antibodies to both putative envelope glycoproteins

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900083-9

7 January 2021

Cytotoxic T cells and viral hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900083-9

7 January 2021

Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900083-9

7 January 2021

Hepatitis C virus: the major causative agent of viral non-A, non-B hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900083-9

7 January 2021

Virosomes reconstituted from human immunodeficiency virus proteins and lipids

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900083-9

7 January 2021

A virosome vaccine antigen delivery system does not stimulate an antiphospholipid antibody response in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900083-9

7 January 2021

Comparison of serum and liver hepatitis C virus quasispecies in HCV-related hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900083-9

7 January 2021

CD40 activation in vivo overcomes peptide-induced peripheral cytotoxic T-lymphocyte tolerance and augments anti-tumor vaccine efficacy

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900083-9

7 January 2021

Experimental vaccine activities of recombinant E1 and E2 glycoproteins and hypervariable region 1 peptides of hepatitis C virus in chimpanzees

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900083-9

7 January 2021

Prevention of hepatitis C virus infection in chimpanzees after antibody-mediated in vitro neutralization

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900083-9

7 January 2021

Prevention of hepatitis C virus infection in chimpanzees by hyperimmune serum against the hypervariable region 1 of the envelope 2 protein

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900083-9

7 January 2021

Simultaneous vaccination for hepatitis A and B.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900083-9

7 January 2021

Immunopotentiating reconstituted influenza virus virosome vaccine delivery system for immunization against hepatitis A

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900083-9

7 January 2021

Immunogenicity of new virosome influenza vaccine in elderly people

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900083-9

7 January 2021

Clinical implications of viral quasispecies heterogeneity in chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900083-9

7 January 2021

Engineered liposomes and virosomes for delivery of macromolecules

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900083-9

7 January 2021

Cross-presentation, dendritic cells, tolerance and immunity

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900083-9

7 January 2021

Immunogenicity and adverse effects of inactivated virosome versus alum-adsorbed hepatitis A vaccine: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900083-9

7 January 2021

Induction of CTL responses by simultaneous administration of liposomal peptide vaccine with anti-CD40 and anti-CTLA-4 mAb

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900083-9

7 January 2021

Adjuvant activity of incomplete Freund's adjuvant

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900083-9

7 January 2021

Molecular mimicry of human cytochrome P450 by hepatitis C virus at the level of cytotoxic T cell recognition

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900083-9

7 January 2021

Virosomes: evolution of the liposome as a targeted drug delivery system

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900083-9

7 January 2021

Protection against lethal Sendai virus infection by in vivo priming of virus-specific cytotoxic T lymphocytes with a free synthetic peptide

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900083-9

7 January 2021

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900083-9

1 reference

7 January 2021

Evaluation of hepatitis C virus protein epitopes for vaccine development

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900083-9

7 January 2021

Protective humoral response against pneumococcal infection in mice elicited by recombinant bacille Calmette-Guérin vaccines expressing pneumococcal surface protein A.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900083-9

7 January 2021

Peptide vaccination using nonionic block copolymers induces protective anti-viral CTL responses

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900083-9

7 January 2021

Antibodies directed to envelope proteins of hepatitis C virus outside of hypervariable region 1.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900083-9

7 January 2021

Replication of subgenomic hepatitis C virus RNAs in a hepatoma cell line

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900083-9

7 January 2021

Inactivated virosome hepatitis A vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900083-9

7 January 2021

In vivo antigen loading and activation of dendritic cells via a liposomal peptide vaccine mediates protective antiviral and anti-tumour immunity

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900083-9

7 January 2021

Hepatitis C virus (HCV) circulates as a population of different but closely related genomes: quasispecies nature of HCV genome distribution

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900083-9

7 January 2021

Infectious entry pathway of influenza virus in a canine kidney cell line

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900083-9

7 January 2021

Induction of sustained and elevated immune responses to weakly immunogenic synthetic malarial peptides by encapsulation in biodegradable polymer microspheres

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900083-9

7 January 2021

Induction of a cytotoxic T lymphocyte response by immunization with a malaria specific CTL peptide entrapped in biodegradable polymer microspheres

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900083-9

7 January 2021

Virosomes as carriers for combined vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900083-9

7 January 2021

Continuous human cell lines inducibly expressing hepatitis C virus structural and nonstructural proteins

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900083-9

7 January 2021

Tightly regulated expression of the entire hepatitis C virus structural region in continuous human cell lines

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900083-9

7 January 2021

Expression of hepatitis C virus proteins does not interfere with major histocompatibility complex class I processing and presentation in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900083-9

7 January 2021

Development of a plant-derived subunit vaccine candidate against hepatitis C virus

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900083-9

7 January 2021

Typing hepatitis C virus by polymerase chain reaction with type-specific primers: application to clinical surveys and tracing infectious sources

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900083-9

7 January 2021

Differences in hypervariable region 1 quasispecies of hepatitis C virus in human serum, peripheral blood mononuclear cells, and liver

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900083-9

7 January 2021

DNA prime-canarypox boost with polycistronic hepatitis C virus (HCV) genes generates potent immune responses to HCV structural and nonstructural proteins

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900083-9

7 January 2021

DNA prime/canarypox boost-based immunotherapy of chronic hepatitis B virus infection in a chimpanzee

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900083-9

7 January 2021

A prime-boost approach to HIV preventive vaccine using a recombinant canarypox virus expressing glycoprotein 160 (MN) followed by a recombinant glycoprotein 160 (MN/LAI). The AGIS Group, and l'Agence Nationale de Recherche sur le SIDA.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900083-9

7 January 2021

Viral escape by selection of cytotoxic T cell-resistant virus variants in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900083-9

7 January 2021

Characterization of hepatitis C virus core-specific immune responses primed in rhesus macaques by a nonclassical ISCOM vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900083-9

7 January 2021

Structure, genomic organization, replication and variability of hepatitis C virus.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900083-9

7 January 2021

The hepatitis C virus: Overview

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900083-9

7 January 2021

Peptide-induced antiviral protection by cytotoxic T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900083-9

7 January 2021

Neutralizing antibodies against hepatitis C virus and the emergence of neutralization escape mutant viruses

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900083-9

7 January 2021

Use of intrinsic and extrinsic helper epitopes for in vivo induction of anti-hepatitis C virus cytotoxic T lymphocytes (CTL) with CTL epitope peptide vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900083-9

7 January 2021

A proposed system for the nomenclature of hepatitis C viral genotypes

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900083-9

7 January 2021

Induction of virus-specific cytotoxic T lymphocytes by in vivo electric administration of peptides

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900083-9

7 January 2021

Persistent hepatitis C virus infection in a chimpanzee is associated with emergence of a cytotoxic T lymphocyte escape variant

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900083-9

7 January 2021

The structure and function of the hemagglutinin membrane glycoprotein of influenza virus

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900083-9

7 January 2021

Immunology taught by viruses

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900083-9

7 January 2021

10.1016/S0161-5890(01)00083-9

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11741697%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

1 reference